Clinical trial Recruiting at 1 site Interventional Ages 60 and up

Expressive art therapy plus exercise for older adults with chronic low back pain

Official title: A Pilot Randomized Controlled Trial Exploring the Use of Supervised Group Art Therapy Among Older Adults With Chronic Low Back Pain: Feasibility, Potential Efficacy, and Participant Experiences

Run by The Hong Kong Polytechnic University · NCT07141082 · Data updated 2026-11-12

This project will try combining group expressive art activities with supervised exercise to see if it reduces pain and improves function in adults aged 60 and over with chronic low back pain.

Quick facts

Study typeInterventional
Ages60 Years and up
SexAll
Enrollment30 (estimated)
SponsorThe Hong Kong Polytechnic University
Academic / other
Locations1 site (Hong Kong)
StatusRecruiting
StartedAugust 2, 2025
Main results expectedDecember 1, 2026
Study endsDecember 1, 2027
Registry record updatedSeptember 8, 2025
Trial IDNCT07141082 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 60 or older with non-specific low back pain lasting at least three months who have sought medical care, can read and write Traditional Chinese, and meet the MoCA-5 cognitive cutoff.

Probably not a fit

Patients with malignant pain, lumbar spinal stenosis, confirmed dementia or severe cognitive impairment, serious major medical or psychiatric disorders, or those already receiving physiotherapy or psychological treatments are unlikely to benefit or be eligible for this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a pilot randomized controlled trial that compares supervised group expressive art therapy combined with exercise to exercise alone in older adults with non-specific chronic low back pain. The trial uses a mixed-methods design with quantitative questionnaires measuring pain intensity, functional ability, psychological flexibility, and health-related quality of life, alongside qualitative semi-structured focus groups and interviews. Primary aims are feasibility metrics including recruitment, retention, and adherence, and secondary aims are preliminary signals of clinical benefit. Sessions are delivered in person and participants must read and write Traditional Chinese and meet cognitive screening criteria.

Why it matters

Potential benefit: If successful, the combined expressive art and exercise program could reduce pain, improve physical function, and enhance quality of life for older adults with chronic low back pain.

How similar studies have gone: Small pilot studies and art-based pain interventions have suggested benefits for coping and mood in chronic pain, but rigorous randomized evidence for expressive art therapy plus exercise in older adults with CLBP is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* aged 60 years and above
* currently experiencing non-specific low back pain for at least three months
* who have sought medical treatment for CLBP
* can read and write in Traditional Chinese
* MoCA-5 of 18 or above

Exclusion Criteria:

* malignant pain
* lumbar spinal stenosis
* confirmed dementia
* severe cognitive impairment
* serious major medical or psychiatric disorders
* currently receiving physiotherapy, cognitive therapy, or psychological treatments

Where it's running

  • Department of Rehabilitation Sciences, The Hong Kong Polytechnic University
    Hong Kong, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.